Extrait

The primary objectives of this study are to compare the efficacy, safety, and tolerability of carisbamate as adjunctive treatment of partial onset seizures, relative to placebo, as measured by the: -Percent reduction in partial onset seizure frequency from baseline relative to the entire double blind treatment phase. -Responder rate from baseline relative to the entire double-blind treatment phase.

Critère d'inclusion

• Epilepsy with Partial Onset Seizures

Liens

• ictrp
• euctr